0001415889-22-003935.txt : 20220407 0001415889-22-003935.hdr.sgml : 20220407 20220407160307 ACCESSION NUMBER: 0001415889-22-003935 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220405 FILED AS OF DATE: 20220407 DATE AS OF CHANGE: 20220407 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boulding Mark Elliott CENTRAL INDEX KEY: 0001578852 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 22813862 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 form4-04072022_010455.xml X0306 4 2022-04-05 0001070081 PTC THERAPEUTICS, INC. PTCT 0001578852 Boulding Mark Elliott C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 false true false false EXEC. VP AND CLO Common Stock 2022-04-05 4 M 0 5 11.23 A 61115 D Common Stock 2022-04-05 4 S 0 5 45 D 61110 D Stock Option (Right to Buy) 11.23 2022-04-05 4 M 0 5 11.23 D 2027-01-02 Common Stock 5 2276 D Stock Option (Right to Buy) 51 2025-01-01 Common Stock 85600 85600 D Stock Option (Right to Buy) 30.86 2026-01-03 Common Stock 70000 70000 D Stock Option (Right to Buy) 33.02 2029-01-21 Common Stock 72500 72500 D Stock Option (Right to Buy) 33.02 2029-01-21 Common Stock 17500 17500 D Stock Option (Right to Buy) 51.16 2030-01-28 Common Stock 59500 59500 D Stock Option (Right to Buy) 66.49 2031-01-05 Common Stock 59500 59500 D Stock Option (Right to Buy) 38.10 2032-01-06 Common Stock 54000 54000 D This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 2, 2021. Currently exercisable. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021. This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022. This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023. /s/ Avraham S. Adler, Attorney-in-Fact 2022-04-07